Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-14-033346
Filing Date
2014-05-23
Accepted
2014-05-23 13:59:12
Documents
8
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K/A v379637_10ka.htm 10-K/A 592139
2 EXHIBIT 23.1 v379637_exh23x1.htm EX-23.1 3326
3 EXHIBIT 31.1 v379637_exh31x1.htm EX-31.1 14640
4 EXHIBIT 31.2 v379637_exh31x2.htm EX-31.2 14274
5 EXHIBIT 32.1 v379637_exh32x1.htm EX-32.1 6953
6 EXHIBIT 32.2 v379637_exh32x2.htm EX-32.2 6926
7 GRAPHIC line.gif GRAPHIC 43
8 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-14-033346.txt   639789
Mailing Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060
Business Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060 650-888-2422
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23930 | Film No.: 14866653
SIC: 2836 Biological Products, (No Diagnostic Substances)